Dynamical behavior of epidemiological models with nonlinear incidence rates, Journal of Mathematical Biology, vol.31, issue.4, pp.359-380, 1987. ,
DOI : 10.1007/978-1-4612-6374-6
Mutations of bacteria from virus sensitivity to virus 562 resistance, Genetics, vol.28, pp.491-511, 1943. ,
, , p.564
, , 2014.
, Phage neutralization by sera of patients receiving phage therapy, Viral Immunol, vol.27, pp.295-304
, , 2016.
, Antiphage activity of sera during phage therapy in relation to its outcome. Future microbiology, p.569
,
Oral application of T4 571, 2015. ,
, phage induces weak antibody production in the gut and in the blood, Viruses, vol.7, pp.4783-4799
, , p.573
A novel immunodeficient mouse 574 model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous 575, 1999. ,
, cytokine administration for human hematopoietic stem cell engraftment, J Interferon Cytokine, vol.576
, Res, vol.19, pp.533-541
, , 1996.
, Long-circulating bacteriophage as antibacterial agents, Proc Natl Acad Sci U S A, vol.93, pp.3188-3192
, , 2012.
, Repeatability and contingency in the evolution of a key innovation in phage lambda, Science, vol.581, issue.335, pp.428-432
M??nage ?? trois in the human gut: interactions between host, bacteria and phages, Nature Reviews Microbiology, vol.102, issue.7, 2017. ,
DOI : 10.1073/pnas.0504062102
Gyrase Inhibitors and Other DNA-Damaging Agents, Journal of Biomolecular Screening, vol.45, issue.56, pp.855-864, 2007. ,
DOI : 10.1128/AAC.45.1.105-116.2001
In vivo 588 imaging of bioluminescent Pseudomonas aeruginosa in an acute murine airway infection model, p.589, 2014. ,
, Pathog Dis, vol.72, pp.74-77
Intrinsic Antimicrobial 591, 2015. ,
, Resistance Determinants in the Superbug Pseudomonas aeruginosa, pp.1603-01615
Evaluation and Management of Patients With Isolated Neutropenia, Seminars in Hematology, vol.50, issue.3, pp.198-206, 2013. ,
DOI : 10.1053/j.seminhematol.2013.06.010
ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.60, issue.2, pp.744-751, 2016. ,
DOI : 10.1128/AAC.01426-15
, , p.598, 2005.
, neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury, Am J, p.599
, Physiol Lung Cell Mol Physiol, vol.289, pp.807-815
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial, Journal of Wound Care, vol.57, issue.6, pp.237-238, 2009. ,
DOI : 10.1016/S0741-5214(99)70076-5
Phage therapy: awakening a sleeping giant, Emerging Topics in Life Sciences, vol.1, issue.1, pp.93-103, 2017. ,
DOI : 10.1042/ETLS20170002
On representing network heterogeneities in the incidence rate of simple epidemic models, Ecological Complexity, vol.3, issue.1, pp.80-90, 2006. ,
DOI : 10.1016/j.ecocom.2005.09.001
A century of the phage: past, present and future, Nature Reviews Microbiology, vol.494, issue.12, p.608, 2015. ,
DOI : 10.1038/nature11927
, Rev Microbiol, vol.13, pp.777-786
, , p.610
Changing Epidemiology of the Respiratory Bacteriology of Patients With, p.611, 2016. ,
, Cystic Fibrosis. Chest, vol.149, pp.390-400
, , p.613
Oral application of Escherichia coli bacteriophage: safety 614 tests in healthy and diarrheal children from Bangladesh, Environ Microbiol, p.615, 2016. ,
, , p.616
Oral Phage Therapy of Acute Bacterial, p.617, 2016. ,
, Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh, p.618
, EBioMedicine, vol.4, pp.124-137
Cutting Edge: Myeloid Differentiation Factor 88 Is Essential for Pulmonary Host Defense against Pseudomonas aeruginosa but Not Staphylococcus aureus, The Journal of Immunology, vol.172, issue.6, pp.3377-3381, 2004. ,
DOI : 10.4049/jimmunol.172.6.3377
URL : http://www.jimmunol.org/content/172/6/3377.full.pdf
Successful treatment of experimental Escherichia coli 623 infections in mice using phage: its general superiority over antibiotics, J Gen Microbiol, vol.128, issue.624, pp.307-318, 1982. ,
, , p.626, 2014.
, inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis, p.627
, Cyst Fibros, vol.13, pp.172-178
Bacteriophage Therapy, p.629, 2015. ,
, Formulation Strategies and Human Clinical Trials, Annu Rev Virol, vol.2, pp.599-618
MyD88: A Critical Adaptor Protein in Innate Immunity Signal Transduction, The Journal of Immunology, vol.190, issue.1, pp.3-4, 2013. ,
DOI : 10.4049/jimmunol.1203103
Morphometry of the human lung, 1963. ,
Quantitative viral ecology: Dynamics of viruses and their microbial hosts 634, 2015. ,
Alternative stable states in host???phage dynamics, Theoretical 636 Ecology, pp.13-19, 2008. ,
DOI : 10.1007/978-1-4684-5409-3_1
Human 638, 2005. ,
, airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by 639
, Toll-like receptor 5, Infect Immun, vol.73, pp.7151-7160